Real world use of long-acting cabotegravir and rilpivirine in a HIV centre in Hong Kong

被引：0
|
作者：
Chan, M. C. J. [1 ]
Chik, S. H. T. [1 ]
Lamb, S. S. [1 ]
Choi, Y. C. C. [1 ]
Lau, W. T. A. [1 ]
Leung, C. S. E. [1 ]
To, P. Y. L. [1 ]
Lau, P. L. D. [1 ]
Tsang, T. Y. O. [1 ]
机构：
[1] Hosp Author Infect Dis Ctr, Hong Kong, Peoples R China
来源：
HIV MEDICINE | 2023年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
814
引用
收藏
页码：155 / 156
页数：2
相关论文
共 50 条
  • [41] Real life data on clinical and laboratory outcomes of long acting cabotegravir and rilpivirine in people with HIV
    Mazzitelli, M.
    Agostini, E.
    Sasset, L.
    Leoni, D.
    Gardin, S.
    Presa, N.
    Putaggio, C.
    Bragato, B.
    Parisi, S.
    Cattelan, A.
    HIV MEDICINE, 2023, 24 : 152 - 153
  • [42] Therapeutic review of cabotegravir/rilpivirine long-acting antiretroviral injectable and implementation considerations at an HIV specialty clinic
    Howe, Zach W.
    Norman, Sarah
    Lueken, Abbie F.
    Huesgen, Emily
    Farmer, Eric K.
    Jarrell, Kaitlyn
    Mathis, Joscelyn E.
    Bonham, Kyle W.
    Hahn, Julie
    PHARMACOTHERAPY, 2021, 41 (08): : 686 - 699
  • [43] Patient-reported outcomes in switching to long-acting cabotegravir/rilpivirine: a real-life experience
    Carraro, Anna
    Marocco, Raffaella
    Mancarella, Giulia
    Zuccala, Paola
    Ansaldo, Lorenzo
    De Maria, Sara
    Corazza, Sara
    Grimaldi, Alessandra
    Gasperin, Andrea
    Del Borgo, Cosmo
    Lichtner, Miriam
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2024, 27 : 116 - 116
  • [44] Early Experience and Effectiveness of Long-Acting Injectable Cabotegravir and Rilpivirine in a South Side Chicago HIV Clinic
    Liegeon, Geoffroy
    Kaperak, Christopher
    Friedman, Eleanor E.
    Djuricich, Paul
    Dawdani, Alicia
    Stafford, Kane
    Plotkin, Sophie
    Schmitt, Jessica
    Hazra, Aniruddha
    Christopoulos, Katerina A.
    Schneider, John A.
    Mcnulty, Moira C.
    OPEN FORUM INFECTIOUS DISEASES, 2025, 12 (03):
  • [45] Exploring predictors of HIV-1 virologic failure to long-acting cabotegravir and rilpivirine: a multivariable analysis
    Cutrell, Amy G.
    Schapiro, Jonathan M.
    Perno, Carlo F.
    Kuritzkes, Daniel R.
    Quercia, Romina
    Patel, Parul
    Polli, Joseph W.
    Dorey, David
    Wang, Yongwei
    Wu, Sterling
    Van Eygen, Veerle
    Crauwels, Herta
    Ford, Susan L.
    Baker, Mark
    Talarico, Christine L.
    St Clair, Marty
    Jeffrey, Jerry
    White, C. Thomas
    Vanveggel, Simon
    Vandermeulen, Kati
    Margolis, David A.
    Aboud, Michael
    Spreen, William R.
    van Lunzen, Jan
    AIDS, 2021, 35 (09) : 1333 - 1342
  • [46] Evaluating cabotegravir/rilpivirine long-acting, injectable in the treatment of HIV infection: emerging data and therapeutic potential
    Fernandez, Cristina
    van Halsema, Clare L.
    HIV AIDS-RESEARCH AND PALLIATIVE CARE, 2019, 11 : 179 - 192
  • [47] Long-Acting Cabotegravir/Rilpivirine Concentrations in Combination With Intravenous Rifampin: A Case Report
    Sunagawa, Shawnalyn W.
    Havens, Joshua P.
    Podany, Anthony
    Walker, Bryan
    Scarsi, Kimberly K.
    Bares, Sara H.
    OPEN FORUM INFECTIOUS DISEASES, 2023, 10 (12):
  • [48] Characterization of a case of virological failure after switch to long-acting cabotegravir and rilpivirine
    Mazzitelli, Maria
    Avolio, Antonio
    Carandina, Riccardo
    Parisi, Saverio
    Wensing, Annemarie
    Cattelan, Annamaria
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2024, 79 (08) : 2074 - 2076
  • [49] Compassionate use of long-acting cabotegravir plus rilpivirine for people living with HIV-1 in need of parenteral antiretroviral therapy
    D'Amico, Ronald
    Gomis, Santiago Cenoz
    Moodley, Riya
    Van Solingen-Ristea, Rodica
    Baugh, Bryan
    Van Landuyt, Erika
    Van Eygen, Veerle
    Min, Sherene
    Cutrell, Amy
    Foster, Caroline
    Chilton, Daniella
    Allard, Sabine D.
    Ruiter, Annemiek
    HIV MEDICINE, 2023, 24 (02) : 202 - 211
  • [50] In Silico Dose Prediction for Long-Acting Rilpivirine and Cabotegravir Administration to Children and Adolescents
    Rajith K. R. Rajoli
    David J. Back
    Steve Rannard
    Caren Freel Meyers
    Charles Flexner
    Andrew Owen
    Marco Siccardi
    Clinical Pharmacokinetics, 2018, 57 : 255 - 266
12345